A review of the technical aspects of drug nebulization
- PMID: 11028259
- DOI: 10.1023/a:1008786600530
A review of the technical aspects of drug nebulization
Abstract
Nebulizers are widely used for the inhalation of drug solutions in a variety of respiratory diseases. The efficacy of nebulizer therapy is influenced by a great number of factors, including the design of the device and the characteristics of the drug solution. Incorrect cleaning, maintenance and disinfection procedures may change the nebulizer performance in time, whereas patient factors can influence the lung deposition of the generated aerosol. In this review the technical aspects of nebulization of drug solutions will be discussed. Two main parameters are generally used to evaluate the performance of nebulizers: the droplet size distribution of the aerosol and the drug output rate. The droplet size distribution and the drug output rate are basically determined by the design and user conditions of the nebulizer. A higher gas flow of the compressor in a jet nebulizer or a higher vibration frequency of the piezo electric crystal in an ultrasonic nebulizer, decreases the droplet size. The choice of the type of nebulizer for nebulization of a certain drug solution may initially be based on laboratory evaluation. The major part of the mass or volume distribution should preferably correspond with aerodynamic particle diameters in the range of 1 to 5 micrometer. The intended drug output must be realized within a reasonable nebulization time (less than 30 min). From the drug output only a minor fraction will be deposited in the lung. The relation between in vitro and in vivo deposition is only partly understood and to date it has not been possible to predict drug delivery only from in vitro studies on nebulizers. Therefore, studies in patients should be performed before a drug solution for nebulization can be recommended for clinical practice. The mechanical properties of nebulizers are likely to change during use. An average utilization time of nebulizers is not available. Therefore, the performance of nebulizers should be checked periodically. Patient compliance in nebulizer therapy is relatively low. This is partly due to the fact that, at present, drug solutions for nebulizers cannot be administered efficiently within a short period of time. More efficient systems should be developed. If possible, nebulizers should be substituted to more efficient systems, e.g. dry powder inhalers or metered dose inhalers.
Similar articles
-
Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.Respir Care. 2015 Jan;60(1):38-46. doi: 10.4187/respcare.02490. Epub 2014 Dec 16. Respir Care. 2015. PMID: 25516995
-
Design principles of liquid nebulization devices currently in use.Respir Care. 2002 Nov;47(11):1257-75; discussion 1275-8. Respir Care. 2002. PMID: 12425742 Review.
-
Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.Pediatr Crit Care Med. 2013 Feb;14(2):e98-102. doi: 10.1097/PCC.0b013e3182712783. Pediatr Crit Care Med. 2013. PMID: 23287904
-
Nebulizers for drug delivery to the lungs.Expert Opin Drug Deliv. 2015 Jun;12(6):889-900. doi: 10.1517/17425247.2015.995087. Epub 2014 Dec 23. Expert Opin Drug Deliv. 2015. PMID: 25534396 Review.
-
Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.Int J Pharm. 1999 Nov 5;189(2):205-14. doi: 10.1016/s0378-5173(99)00251-3. Int J Pharm. 1999. PMID: 10536249
Cited by
-
Low-dose intrapulmonary drug delivery device for studies on next-generation therapeutics in mice.J Control Release. 2023 Jul;359:287-301. doi: 10.1016/j.jconrel.2023.05.039. Epub 2023 Jun 14. J Control Release. 2023. PMID: 37301267 Free PMC article.
-
Numerical modelling of micron particle inhalation in a realistic nasal airway with pediatric adenoid hypertrophy: A virtual comparison between pre- and postoperative models.Front Pediatr. 2023 Feb 23;11:1083699. doi: 10.3389/fped.2023.1083699. eCollection 2023. Front Pediatr. 2023. PMID: 36911037 Free PMC article.
-
Fugitive aerosols in the intensive care unit: a narrative review.Ann Transl Med. 2021 Apr;9(7):592. doi: 10.21037/atm-20-2280. Ann Transl Med. 2021. PMID: 33987290 Free PMC article. Review.
-
Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model.Pharm Res. 2006 May;23(5):901-11. doi: 10.1007/s11095-006-9904-6. Epub 2006 May 5. Pharm Res. 2006. PMID: 16715380
-
Nebulization of Single-Chain Tissue-Type and Single-Chain Urokinase Plasminogen Activator for Treatment of Inhalational Smoke-Induced Acute Lung Injury.J Drug Deliv Sci Technol. 2018 Aug;48:19-27. doi: 10.1016/j.jddst.2018.04.013. Epub 2018 Apr 30. J Drug Deliv Sci Technol. 2018. PMID: 30123328 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical